Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov-Dec;35(6):3305-3313.
doi: 10.21873/invivo.12626.

Combination of the CD8+:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 Patients

Maria G Detsika  1 , Eirini Grigoriou  2 , Katherina Psarra  2 , Edison Jahaj  1 , Stamatios Tsipilis  1 , Nikolaos Athanassiou  1 , Alexandros Zacharis  1 , Ioanna Dimopoulou  1 , Stylianos E Orfanos  1 , Alexandra Tsirogianni  2 , Anastasia Kotanidou  3
Affiliations

Combination of the CD8+:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 Patients

Maria G Detsika et al. In Vivo. 2021 Nov-Dec.

Abstract

Background: The study provides a novel prediction model for COVID-19 progression and outcome by the combination of the CD8+: B-cells ratio with neutrophil-to-lymphocyte ratio (NLR).

Patients and methods: Immune phenotyping was performed in 120 COVID-19 patients.

Results: A decrease in CD8+:B-cell (p<0.0001) and in lymphocyte-to-CRP (LCR) ratio (p<0.0001) was observed in intubated patients versus non-intubated with an increase for CD4+:CD8+ (p<0.01), NLR (p<0.0001) and CRP: Albumin (p<0.001). Receiving operating curve (ROC) analysis predicting requirement for mechanical ventilation revealed the highest AUC for CD8+:B-cells, (AUC=0.795, p<0.001) versus NLR (AUC=0.783, p<0.001), LCR (AUC=0.779, p<0.001), Albumin:CRP (AUC=0.750, p<0.001) and CD4+:CD8+ (AUC=0.779, p<0.001). Combination of the CD8+: B-cell ratio with the NLR increased the AUC (AUC=0.845, p<0.001). The combined ratios correlated with outcome defined as duration of hospital (r=0.435, p<0.001) or ICU stay (r=0.596, p<0.001).

Conclusion: Combination of the CD8+: B-cell ratio and NLR serves as a useful prognostic tool for COVID-19 patient progression.

Keywords: COVID-19; SARS-COV-2; disease progression; immune phenotyping; intensive care unit; mechanical ventilation; prognostic markers.

PubMed Disclaimer

Conflict of interest statement

The Authors declare no competing interests.

Figures

Figure 1
Figure 1. Representative gating strategy for immune profiling of coronavirus disease 2019 (COVID-19) patients.
Figure 2
Figure 2. Severe decrease of the CD8+: B-cell ratio in intubated patients. A significant decrease of the CD8+: B-cell ratio was observed between non-intubated and intubated (A) as well as an increase for CD4+:CD8+ (B), neutrophil-to-lymphocyte ratio (NLR), a decrease in lymphocyte-toCRP ratio (C) and an increase in CRP:Albumin ratio (E). Statistical analysis was performed by Mann-Whitney U-test. ****p<0.0001, ***p<0.001.
Figure 3
Figure 3. Severe decrease of the CD8+: B-cell ratio in non-survivors versus survivors. A significant decrease of the CD8+: B-cell ratio was observed between non-intubated and intubated patients (A) as well as an increase for CD4+:CD8+ (B), neutrophil-to-lymphocyte ratio (NLR), a decrease in lymphocyte-to-CRP ratio (C) and an increase in CRP:Albumin (E). Statistical analysis was performed by Mann-Whitney U-test. *p<0.05, **p<0.01, ****p<0.0001.
Figure 4
Figure 4. Prognostic value of the CD8+: B cell ratio. Receiving operating curve analysis for predicting the requirement of mechanical ventilation in COVID-19 patients by (A) CD8+:B cell, CD4+:CD8+, neutrophil-toly mphocyte ratio (NLR), lymphocyte-to-CRP ratio (LCR) and CRP:Albumin ratio and (B) by the combination of CD8+: B cells with NLR.
Figure 5
Figure 5. Combined CD8+: B cell and NLR ratios as a prognostic tool for COVID-19 outcome. Correlation analysis revealed a negative correlation of CD8+:B cells with (A) outcome defined as duration of hospitalization (days) and (B) outcome defined as duration of ICU stay. Positive correlation with outcome for NLR (C, D) and combined CD8+: B cell ratio with NLR (E, F).
See this image and copyright information in PMC

References

    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Liu J, Li S, Liu J, Liang B, Wang X, Wang H, Li W, Tong Q, Yi J, Zhao L, Xiong L, Guo C, Tian J, Luo J, Yao J, Pang R, Shen H, Peng C, Liu T, Zhang Q, Wu J, Xu L, Lu S, Wang B, Weng Z, Han C, Zhu H, Zhou R, Zhou H, Chen X, Ye P, Zhu B, Wang L, Zhou W, He S, He Y, Jie S, Wei P, Zhang J, Lu Y, Wang W, Zhang L, Li L, Zhou F, Wang J, Dittmer U, Lu M, Hu Y, Yang D, Zheng X. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763. - DOI - PMC - PubMed
    1. Calvet J, Gratacós J, Amengual MJ, Llop M, Navarro M, Moreno A, Berenguer-Llergo A, Serrano A, Orellana C, Cervantes M. CD4 and CD8 lymphocyte counts as surrogate early markers for progression in SARS-CoV-2 pneumonia: A prospective study. Viruses. 2020;12(11):1277. doi: 10.3390/v12111277. - DOI - PMC - PubMed
    1. Detsika MG, Ampelakiotou K, Grigoriou E, Psarra K, Jahaj E, Roussos C, Dimopoulou I, Orfanos SE, Tsirogianni A, Kotanidou A. A novel ratio of CD8+:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome. Virology. 2021;556:79–86. doi: 10.1016/j.virol.2021.01.002. - DOI - PMC - PubMed
    1. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi: 10.1172/JCI137244. - DOI - PMC - PubMed